datetime,headline,summary,related,lang,source
2020-10-09 07:36:10-05:00,Elanco é alvo de investidor ativista,"Sachem adquiriu US$ 1,2 bi em ações para pressionar por mudanças administrativas A Sachem Head Capital Management, um investidor ativista, que faz campanha por transformações nas empresas nas quais investe, fez a maior aposta em sua história ao comprar participação de US$ 1,2 bilhão na Elanco Animal Health Inc., para pressionar por mudanças administravas em suas operações. Matéria exclusiva para assinantes. Para ter acesso completo, acesse o link da matéria e faça o seu cadastro.",ELAN,pt,Valor Econômico
2020-07-30 16:30:52-05:00,ELANCO ANIMAL HEALTH INC (ELAN) Q2 2020 Earnings Call Transcript | The Motley Fool,"ELAN earnings call for the period ending June 30, 2020.",ELAN,en,The Motley Fool
2020-07-17 11:00:00-05:00,The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Elanco Animal Health Incorporated (ELAN),"LOS ANGELES--(BUSINESS WIRE)---- $ELAN #classaction--The Law Offices of Frank R. Cruz reminds investors of the upcoming July 20, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Elanco Animal Health Incorporated (“Elanco” or the “Company”) (NYSE: ELAN) securities between January 10, 2020 and May 6, 2020, inclusive (the “Class Period”). If you are a shareholder who suffered a loss, click here to participate. On May 7, 2020, before the market opened, Elanco ann",ELAN,en,Business Wire
2020-06-12 18:55:00-05:00,ELAN INVESTOR ALERT: Kirby McInerney LLP Announces That a Class Action Lawsuit Has Been Filed Against Elanco Animal Health Incorporated and Encourages Investors to Contact the Firm Before July 20,"NEW YORK--(BUSINESS WIRE)---- $ELAN #classaction--The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Southern District of Indiana on behalf of those who acquired Elanco Animal Health Incorporated (“Elanco” or the “Company”) (NYSE: ELAN) securities during the period from January 10, 2020 through May 6, 2020. Investors have until July 20, 2020 to apply to the Court to be appointed as lead plaintiff in the lawsuit. The lawsuit alleges that",ELAN,en,Business Wire
2020-05-26 10:00:00-05:00,Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Elanco Animal Health Incorporated (ELAN),LOS ANGELES--(BUSINESS WIRE)---- $ELAN #classaction--Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against of Elanco Animal Health Incorporated (ELAN),ELAN,en,Business Wire
2020-05-21 08:11:00-05:00,"SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Elanco Animal Health Incorporated and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",LOS ANGELES--(BUSINESS WIRE)---- $ELAN #ELAN--SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Elanco Animal Health Incorporated.,ELAN,en,Business Wire
2020-05-20 18:29:00-05:00,ELAN CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Elanco Animal Health Incorporated (ELAN),"LOS ANGELES--(BUSINESS WIRE)---- $ELAN #classaction--The Law Offices of Frank R. Cruz announces that it has filed a class action lawsuit in the United States District Court for the Southern District of Indiana captioned Hunter v. Elanco Animal Health Incorporated, et al., (Case No. 20-cv-01460) on behalf of persons and entities that purchased or otherwise acquired Elanco Animal Health Incorporated (“Elanco” or the “Company”) (NYSE: ELAN) securities between January 10, 2020 and May 6, 2020, inclusive (the “Class Perio",ELAN,en,Business Wire
2020-05-20 14:25:00-05:00,ELAN CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Elanco Animal Health Incorporated,LOS ANGELES--(BUSINESS WIRE)---- $ELAN #classaction--ELAN CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Elanco Animal Health Incorporated,ELAN,en,Business Wire
2020-05-18 10:00:00-05:00,"Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Elanco Animal Health Incorporated (ELAN) on Behalf of Investors","LOS ANGELES--(BUSINESS WIRE)---- $ELAN #fraud--Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Elanco Animal Health Incorporated on Behalf of Investors",ELAN,en,Business Wire
2020-05-08 16:00:00-05:00,"Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Elanco Animal Health Incorporated (ELAN) on Behalf of Investors","LOS ANGELES--(BUSINESS WIRE)---- $ELAN #fraud--Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Elanco Animal Health Incorporated on Behalf of Investors",ELAN,en,Business Wire
2020-05-08 14:36:00-05:00,The Law Offices of Frank R. Cruz Announces Investigation on Behalf of Elanco Animal Health Incorporated Investors (ELAN),"LOS ANGELES--(BUSINESS WIRE)---- $ELAN #classaction--The Law Offices of Frank R. Cruz announces an investigation on behalf of Elanco Animal Health Incorporated (""Elanco"" or the ""Company"") (NYSE: ELAN) investors concerning the Company and its officers’ possible violations of federal securities laws. If you are a shareholder who suffered a loss, click here to participate. On May 7, 2020, Elanco announced its financial and operating results for the first quarter of 2020, reporting revenue of $657.7 million and earnings",ELAN,en,Business Wire
2020-05-07 08:25:06-05:00,Elanco Animal Health Incorporated (ELAN) Q1 Earnings and Revenues Miss Estimates,"Elanco Animal Health Incorporated (ELAN) delivered earnings and revenue surprises of -45.83% and -9.94%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?",ELAN,en,Zacks Investment Research
2020-05-06 07:40:00-05:00,Is a Surprise Coming for Elanco (ELAN) This Earnings Season?,Elanco (ELAN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.,ELAN,en,Zacks Investment Research
2020-04-30 11:33:36-05:00,Elanco Animal Health Incorporated (ELAN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?,Elanco Animal Health Incorporated (ELAN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,ELAN,en,Zacks Investment Research
2020-04-20 07:30:00-05:00,Elanco Expands Executive Team to Lead Company Post Bayer Animal Health Acquisition,"GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) announced today it will expand its existing leadership team, adding a Chief Marketing Officer and three commercial leaders to its current Executive Committee. The expanded team adds depth and experience to position Elanco for continued growth. “With our anticipated addition of Bayer Animal Health, we’re looking to ensure we have the right structure and right leadership in place to support the combined organization",ELAN,en,Business Wire
2020-04-09 07:00:00-05:00,"Elanco, VetNOW Collaborate to Expand Access to Veterinary Care, Relieve Impact of COVID-19","GREENFIELD, Ind.--(BUSINESS WIRE)--Today, Elanco Animal Health Incorporated (NYSE: ELAN) and VetNOW announce a collaboration providing veterinarians access to an industry-leading telemedicine platform so they can maintain service to animals and owners – including specialist consultations - during a time when the industry is challenged to find new ways to connect. “The practice of veterinary medicine is changing, and COVID-19 is catalyzing that change. Clinics need that innovation right now, but",ELAN,en,Business Wire
2020-04-07 07:30:00-05:00,Elanco Confirms Date and Conference Call for First Quarter 2020 Financial Results Announcement,"GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) will announce its first quarter 2020 financial results on Thursday, May 7, 2020. Elanco will also conduct a conference call on that day with the investment community and media to further detail the company’s performance. The conference call will begin at 8:00 a.m. eastern time. Investors, media and the general public can access a live webcast of the conference call through the link that will be posted on Elanco’s",ELAN,en,Business Wire
2020-03-27 07:30:00-05:00,The Elanco Foundation Announces Efforts to Support Food Security Amidst COVID-19 Crisis,"GREENFIELD, Ind.--(BUSINESS WIRE)--Today, the recently-formed Elanco Foundation pledged more than $700,000 to help fight rising food insecurity challenges due to the novel coronavirus outbreak. The funds will support organizations and food banks in communities across Elanco Animal Health’s (NYSE: ELAN) footprint, including Gleaners Food Bank of Indiana, the European Food Banks Federation and food banks in Winslow, Maine, Ft. Dodge, Iowa, Clinton, Ind., the Kansas City area, and Greenfield, Ind.",ELAN,en,Business Wire
2020-03-24 05:29:00-05:00,Elanco Provides Business Update Related to COVID-19,"GREENFIELD, Ind.--(BUSINESS WIRE)--As Elanco Animal Health Incorporated (NYSE: ELAN) evaluates the potential impact of the COVID-19 pandemic, it is providing an update on its business and financial position, as well as the actions it is taking to support employees, customers and public health. “In this time of uncertainty, the health and well-being of our employees, customers, animals and the communities where we operate are our top priority,” said Jeff Simmons, Elanco president and CEO. “Our t",ELAN,en,Business Wire
2020-02-27 08:30:00-05:00,Elanco to Participate in Cowen Health Care Conference,"GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the Cowen and Company 40th Annual Health Care Conference on Wednesday, March 4, 2020, in Boston, Mass. Jeff Simmons, president and chief executive officer, will participate in a fireside chat at 9:20 a.m. Eastern Time. A live audio webcast will be available on the “Events and Presentations” section of Elanco’s Investor website at https://investor.elanco.com/investors/events-and-presentations/ev",ELAN,en,Business Wire
2020-02-21 08:30:00-05:00,Elanco to Participate in the Bank of America Merrill Lynch Animal Health Summit,"GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the Bank of America Merrill Lynch Animal Health Summit on Monday, Feb. 24, 2020, in New York, N.Y. Todd Young, executive vice president and CFO, will represent the company and respond to questions from analysts. He is scheduled to present at 3:05 p.m. ET. A live audio webcast will be available on the “Events and Presentations” section of Elanco’s Investor website at https://investor.elanco.com/",ELAN,en,Business Wire
2020-02-19 19:30:48-05:00,ELANCO ANIMAL HEALTH INC (ELAN) Q4 2019 Earnings Call Transcript | The Motley Fool,"ELAN earnings call for the period ending December 31, 2019.",ELAN,en,The Motley Fool
2020-02-19 16:30:00-05:00,Elanco Signs Agreement with Merck Animal Health to Divest Worldwide Rights for Vecoxan®,"GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) announced today it signed an agreement with Merck Animal Health (also known as MSD Animal Health) to divest worldwide rights for Vecoxan® for $55 million in an all-cash deal. Vecoxan® is used for prevention and treatment of coccidiosis in calves and lambs. Divesting the rights to Vecoxan brings divestitures to-date into the $120 million to $140 million revenue range Elanco previously stated it expected across both",ELAN,en,Business Wire
2020-02-19 07:45:04-05:00,Elanco Animal Health Incorporated (ELAN) Q4 Earnings Match Estimates,"Elanco Animal Health Incorporated (ELAN) delivered earnings and revenue surprises of 0.00% and -0.50%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?",ELAN,en,Zacks Investment Research
2020-02-19 06:29:00-05:00,Elanco Animal Health Reports 2019 Fourth Quarter and Full Year Results,"GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) today reported its financial results for the fourth quarter and full year of 2019, the first full year as an independent company. The full year 2019 results reflect the durability and agility of a fit-for-purpose dedicated animal health company driving growth in our Core business, excluding Strategic Exits, and improved profitability through execution of the company's productivity agenda. “In our first full year a",ELAN,en,Business Wire
2020-02-17 08:35:00-05:00,"Elanco’s East Africa Growth Accelerator Delivers $8+ Million in Socio-Economic Value for Smallholder Farmers in East Africa, Progress Against Sustainable Development Goals",Elanco Animal Health Inc. (NYSE: ELAN) today announced that its shared value East Africa Growth Accelerator (EAGA) initiative has delivered a Social R,ELAN,en,Business Wire
2020-02-06 08:30:00-05:00,Stratasys Announces Elchanan (Elan) Jaglom to Step Down as Chairman of the Board of Directors in May,"REHOVOT, Israel--(BUSINESS WIRE)--Stratasys has announced that Elchanan (Elan) Jaglom will step down as Chairman of the Board of Directors on May 17.",ELAN,en,Business Wire
2020-02-04 09:00:00-05:00,Elanco Animal Health Announces Strategic Alliance With Purdue University and Purdue Research Foundation,"GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) today announced a four-year agreement with Purdue University and Purdue Research Foundation with the goal to collaborate and train talent, as Elanco seeks solutions to solve some of the greatest challenges in animal health. The alliance allows Elanco to work side-by-side with Purdue’s leading animal health research scientists with specific expertise in structural biology, protein engineering, microbiome discovery",ELAN,en,Business Wire
2020-01-28 16:30:00-05:00,Elanco Confirms Date and Conference Call for 2019 Fourth Quarter Financial Results,"GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) will announce its 2019 fourth quarter financial results on Wednesday, February 19, 2020. Elanco will also conduct a conference call on that day with the investment community and media to further detail the company’s performance. The conference call will begin at 8:00 a.m. Eastern time. Investors, media and the general public can access a live webcast of the conference call through the link that will be posted on E",ELAN,en,Business Wire
2020-01-23 07:50:26-05:00,Elanco prices common stock and tangible equity unit offerings,"Elanco Animal Health (NYSE:ELAN) has priced its public offerings of 22,694,732 common shares (upsized from 19,159,866 shares) at $32.00 per share and 11M o",ELAN,en,Seeking Alpha
2020-01-23 06:00:00-05:00,Elanco Animal Health Announces Upsizing and Pricing of Common Stock and Pricing of Tangible Equity Unit Offerings,"GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) today announced that is has priced its previously announced concurrent public offerings of 22,694,732 shares of its common stock at $32.00 per share and 11,000,000 of its 5.00% tangible equity units, with a stated amount of $50 per unit. The common stock offering was upsized from the previously announced offering size of 19,159,866 shares of common stock. The common stock offering and tangible equity unit offering",ELAN,en,Business Wire
2020-01-10 06:30:00-05:00,Elanco Announces 2020 Financial Guidance,"GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) today announced its initial financial guidance for 2020, including total revenue expectations in the range of $3.05 billion to $3.11 billion, and Core Revenue, which excludes strategic exits, in the range of $3.00 billion to $3.06 billion. Elanco also expects earnings per share (EPS) for 2020 to be in the range of $0.04 to $0.16 on a reported basis and $1.09 to $1.16 on an adjusted basis. These revenue and EPS exp",ELAN,en,Business Wire
2020-01-08 17:00:00-05:00,Elanco Confirms Date for 2020 Financial Guidance Announcement,"GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) will announce its financial guidance for 2020 on Friday, January 10, 2020. Elanco will also conduct a conference call on that day with the investment community and media to further detail the company’s financial guidance. The conference call will begin at 8 a.m. Eastern time. Investors, media and the general public can access a live webcast of the conference call by visiting https://investor.elanco.com/investors/e",ELAN,en,Business Wire
2020-01-03 08:30:00-05:00,Elanco to Present at the 38th Annual J.P. Morgan Healthcare Conference,"GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the 38th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 14, 2020, in San Francisco, Calif. Jeff Simmons, president and CEO, will represent the company and respond to questions from analysts. He is scheduled to present at 12:30 p.m. ET (9:30 a.m. PT). Investors and other interested parties can view the live audio webcast of the presentation by visiting https://investor.elanco.com/inve",ELAN,en,Business Wire
2019-12-02 16:30:00-05:00,"Elanco Animal Health Appoints Chief Sustainability Officer, Emphasizes Continued Commitment to Advance Well-Being of Animals, People and Planet","GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Inc. (NYSE: ELAN) today announced Sara Place, Ph.D., has joined the company as Chief Sustainability Officer, emphasizing the company’s continued commitment to make an impact on societal challenges by improving the health of animals. Place will join Elanco’s team of scientific experts: Chief Medical Officer Shabbir Simjee and Chief Animal Welfare Officer Michelle Calvo-Lorenzo. The group helps Elanco and its customers identify new opportuni",ELAN,en,Business Wire
2019-11-15 01:14:07-05:00,Elanco Animal Health (NYSE:ELAN) Sets New 1-Year Low at $25.43,"Elanco Animal Health (NYSE:ELAN)’s stock price hit a new 52-week low during mid-day trading on Thursday . The stock traded as low as $25.43 and last traded at $25.70, with a volume of 97899 shares traded. The stock had previously closed at $26.00. ELAN has been the subject of several recent research reports. Cleveland Research […]",ELAN,en,Modern Readers
2019-11-07 13:30:25-05:00,Morgan Stanley Upgrades Elanco Animal Health On Valuation,"While Elanco Animal Health Inc’s (NYSE: ELAN ) current valuation reflects the ongoing investor concerns, the focus is now likely to shift to the positives related to the Bayer transaction, prospects of margin expansion and long-term pipeline potential over 20202, according to Morgan Stanley. The Analyst Morgan Stanley’s David Risinger upgraded Elanco Animal Health from Equal-Weight to Overweight while reducing the price target from $34 to $32. The Thesis Elanco Animal Health’s shares have declined by 15% year to date, significantly underperforming the broader market and key competitor Zoetis Inc (NYSE: ZTS ), Risinger said in the note. Investors currently appear skeptical about the decision … Full story available on Benzinga.com",ELAN,en,Benzinga Feeds
2019-11-06 06:30:00-05:00,Elanco Animal Health Reports Third Quarter Results,"GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) today reported its financial results for the third quarter of 2019 and narrowed its guidance for full year 2019. The results reflect underlying price and volume growth in our targeted growth categories and improved profitability through execution of the company's three-pillar strategy of Innovation, Portfolio and Productivity (IPP). “Elanco’s portfolio approach continues to deliver strong results, with double digi",ELAN,en,Business Wire
2019-10-30 09:34:25-05:00,Earnings Preview: Elanco Animal Health Incorporated (ELAN) Q3 Earnings Expected to Decline,Elanco Animal Health Incorporated (ELAN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,ELAN,en,Zacks Investment Research
2019-10-12 15:02:45-05:00,Is Elanco Animal Health Incorporated (ELAN) A Good Stock To Buy?,"Is Elanco Animal Health Incorporated (NYSE:ELAN) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research. Hedge funds spend millions of dollars on Ivy League graduates, expert networks, and get tips from investment bankers and industry",ELAN,en,ACI Information Group
2019-08-27 06:29:00-05:00,"The Daily Biotech Pulse: Nuvectra Explores Strategic Options, J&J To Contend Opioid Ruling, Sesen Bio Gets New CFO","Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 26) DURECT Corporation (NASDAQ: DRRX ) Stoke Therapeutics Inc (NASDAQ: STOK ) Down In The Dumps (Biotech stocks hitting 52-week lows on Aug. 26) Advaxis, Inc. (NASDAQ: ADXS ) Arbutus Biopharma Corp (NASDAQ: ABUS ) ASLAN PHARMACEU/ADR (NASDAQ: ASLN ) Avanos Medical Inc (NYSE: AVNS ) Cancer Genetics Inc (NASDAQ: CGIX ) Clearside Biomedical Inc (NASDAQ: CLSD ) Elanco Animal Health Inc (NYSE: ELAN )(Bank of America downgraded the shares to Neutral) Neurometrix Inc (NASDAQ: NURO ) Regeneron Pharmaceuticals Inc (NASDAQ: REGN ) Stealth BioTherapeutics Corp (NASDAQ: MITO ) Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH ) Tocagen Inc (NASDAQ: TOCA ) Unity Biotechnology Inc (NASDAQ: UBX ) Zafgen Inc (NASDAQ: ZFGN ) Stocks In Focus Nuvectra To Explore Strategic Options Nuvectra Corp (NASDAQ: NVTR ) announced its decision to explore strategic alternatives to …",ELAN,en,Benzinga
2019-05-19 06:35:57-05:00,Retail On Display (Stocks To Watch Podcast),No summary available.,ELAN,en,Seeking Alpha
2019-05-09 13:28:27-05:00,Elanco Animal Health Incorporated (ELAN) CEO Jeffrey Simmons on Q1 2019 Results - Earnings Call Transcript,No summary available.,ELAN,en,Seeking Alpha
2019-05-09 12:42:21-05:00,Elanco Animal Health Incorporated (ELAN) Q1 2019 Earnings Call Transcript,"ELAN earnings call for the period ending March 31, 2019.",ELAN,en,The Motley Fool
2019-05-09 05:45:35-05:00,Elanco Q1 top line off 1%; lowers revenue guidance,No summary available.,ELAN,en,Seeking Alpha
2019-05-09 05:33:10-05:00,"Elanco beats by $0.02, misses on revenue",No summary available.,ELAN,en,Seeking Alpha
2019-05-08 16:30:52-05:00,Elanco Q1 2019 Earnings Preview,No summary available.,ELAN,en,Seeking Alpha
2019-05-02 08:45:28-05:00,Summers Value Partners - Elanco Animal Health,No summary available.,ELAN,en,Seeking Alpha
2019-04-29 09:02:16-05:00,"Merger Arbitrage Mondays - April 29, 2019",No summary available.,ELAN,de,Seeking Alpha
2019-04-26 20:26:13-05:00,Elanco Animal Health's (ELAN) CEO Jeff Simmons Announces Strategic Investments Update (Transcript),"Elanco Animal Health Incorporated (NYSE:ELAN) Strategic Investments Update Conference Call April 26, 2019 9:00 AM ET Company Participants Jim Greffet – Head of",ELAN,en,Seeking Alpha
2019-04-26 11:33:40-05:00,Elanco Animal Health Announces $245M Stock-For-Stock Acquisition Of Aratana Therapeutics,"Elanco Animal Health Inc (NYSE: ELAN ) announced Friday that it has struck a deal to buy pet therapeutics company Aratana Therapeutics Inc (NASDAQ: PETX ). The two companies are partners on the canine drug Galliprant. What Happened The stock-for-stock deal is worth as much as $245 million, Elanco said. A cash contingent value right of 25 cents per share will be granted to Aratana shareholders on the closing date if the drug capromorelin, known by the brand name Entyce, achieves a set sales target prior to the end of 2021, Elanco said. The deal would grant Aratana shareholders 0.1481 Elanco shares and one cash contingent value right for each Aratana share, and … Full story available on Benzinga.com",ELAN,en,Benzinga
2019-04-25 05:20:47-05:00,2 Funds To Sweat In The Game Of IPOs,No summary available.,ELAN,en,Seeking Alpha
2019-03-18 10:56:07-05:00,5 Stocks With Recent Insider Buying,No summary available.,ELAN,en,Seeking Alpha
2019-03-17 06:48:57-05:00,"Eyes On Boeing, Nvidia, Disney, Nike And WageWorks (Stocks To Watch Podcast)",No summary available.,"ELLI,ELAN",en,Seeking Alpha
2019-02-08 07:14:09-05:00,Lilly launches exchange offer for Elanco shares,No summary available.,ELAN,en,Seeking Alpha
2019-02-06 12:29:30-05:00,"Elanco down 5% after Q4 report, Lilly plan to divest remaining shares",No summary available.,ELAN,en,Seeking Alpha
